ReviewFrontiers in oncology2026
Endonasal flap reconstruction in sinonasal malignancy.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sinonasal malignancies are a broad, yet rare, class of head and neck cancers with a poor prognosis. Surgical resection is the mainstay of treatment for the majority of tumors. Resection of sinonasal malignancies may result in cerebrospinal fluid (CSF) leak, meningitis, pneumocephalus, and prolonged nasal crusting if not appropriately reconstructed. The advent of endoscopic sinus surgery (ESS) has transformed the field and allowed for fully endonasal resection of sinonasal malignancies. The Hadad-Bassagasteguy flap, now colloquially known as the nasoseptal flap, has revolutionized endonasal reconstruction. The nasoseptal flap is a robust mucoperichondrial flap pedicled on the posterior septal artery, providing a rich and reliable blood supply. The nasoseptal flap has become the workhorse of anterior skull base reconstruction given its relative ease of harvest, reliability, low donor site morbidity and success: CSF leaks rates have decreased from > 20% to < 5% with the use of the nasoseptal flap. This review thoroughly discusses the history, use, and techniques for the nasoseptal flap.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.